LoPriore Vincent S

LoPriore Vincent S is listed in filings as Executive Chairman at Hepion Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Apr 27, 2026, including purchase activity. Recent filings connect the profile to Hepion Pharmaceuticals, Inc. (HEPA) and Canton Strategic Holdings Inc (CNTN). The current snapshot covers public activity from Nov 5, 2025 to Apr 27, 2026. Reported amounts are shown as $200.0K to $276.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.